COVID-19 infection among pregnant and non-pregnant women: Comparison of biochemical markers and outcomes during COVID-19 pandemic, A retrospective cohort study.
Ann Med Surg (Lond) 2022;
76:103527. [PMID:
35371473 PMCID:
PMC8958856 DOI:
10.1016/j.amsu.2022.103527]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Revised: 03/20/2022] [Accepted: 03/26/2022] [Indexed: 11/29/2022] Open
Abstract
Background
& Objectives: We conducted this single-centered retrospective study including female patients infected with COVID-19 with aim to compare laboratory findings and the outcomes between pregnant and non-pregnant women infected with COVID-19. Previous data rendered pregnant women as vulnerable population for COVID-19.
Methods
We included 131 patients in our analysis out of which 60 were pregnant females and rest 71 were non-pregnant females.
Results
Factors like fatigue, total leukocyte count (TLC) and neutrophils were higher in pregnant patients, while mean age, fever, hemoglobin, ferritin, D-dimer and use of mechanical ventilation was lower in pregnant patients as compared to non-pregnant females.
Conclusion
Our study concluded that COVID-19 do not show significant high risk of disease severity when compared with non-pregnant females of similar age group.
Previous studies reported that pregnant women are vulnerable population appearing to be at higher risk of morbidity and mortality from COVID-19.
Our study concluded that COVID-19 do not show significant high risk of disease severity in pregnancy when compared with non-pregnant females of similar age group.
Collapse